Intensive BP lowering in ICH

This large trial of patients with acute intracranial hemorrhage randomized them to usual BP care (target SBP <180) or intensive BP care (target SBP <140). Outcomes did not differ between the groups (death or major disability at 90 days), and there was no difference in serious adverse events, but the intensive group did have better overall Rankin scores. Intensive SBP lowering in acute ICH may be advantageous for functional outcomes (abstract).

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment